Science Current Events | Science News | Brightsurf.com
 

Most Viewed Heparin Current Events | Heparin News

Sort By: Relevance | Date

Scientists develop new treatments for Alzheimer's disease
Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer's disease.   view more (2006-10-27)

New treatment for severe malaria
The most dangerous form of malaria is difficult to treat and claims two million lives a year. Now, researchers at Karolinska Institutet in Sweden have developed a powerful new weapon against the disease.   view more (2006-10-02)

Sugars in liver found to clear fats from the bloodstream
Maybe you ate a big, juicy steak for dinner last night, adding a large amount of fat - scientifically known as triglycerides - to your system. For one in ten of us, that could be a big problem.   view more (2007-01-03)

Heparin antibodies may pose risk in heart surgery patients
New research suggests that patients who develop antibodies to the anti-clotting drug heparin nearly double their risk of death or serious complication after heart surgery.   view more (2005-12-05)

Blood clots can be treated by injections at home
Treatment of blood clots in the deep veins of the legs or the lungs with an older, less expensive form of the anticoagulant medication heparin can be just as safe and effective as similar treatment with a newer and more expensive heparin.   view more (2006-08-23)

First guidelines to focus on postoperative atrial fibrillation
he American College of Chest Physicians (ACCP) released today the first evidence-based clinical practice guidelines for the prevention and management of postoperative atrial fibrillation (AF) after cardiac surgery.   view more (2005-08-09)

Mayo researchers explore reasons for complications with kidney failure patients
Mayo Clinic researchers searching for explanations of high mortality rates among kidney failure patients undergoing hemodialysis are focusing their attention on the use of heparin, a drug used to reduce clotting of the blood.   view more (2005-08-18)

Heparin prepared synthetically could replace animal-derived drug
Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.   view more (2006-02-07)

Are blood thinners post-op killers?
New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after surgery   view more (2008-04-01)

Blood-compatible nanoscale materials possible using heparin
Researchers from Rensselaer Polytechnic Institute have engineered nanoscale materials that are blood compatible using heparin, an anticoagulant. The heparin biomaterials have potential for use as medical devices and in medical treatments such as kidney dialysis.   view more (2006-05-08)

Researchers discover new way to reverse poor circulation and heal wounds
Researchers have solved a longstanding mystery about how flexing muscles "tell" nearby blood vessels that they need more blood to perform, according to a study published Feb. 15 in the journal Circulation Research.   view more (2008-02-15)

New anti-blood-thinning drug not as safe as protamine
The results of an international clinical trial led by Duke University Medical Center researchers has shown that a new drug is not a suitable replacement for protamine, a drug that has been used for more than 40 years after coronary artery bypass surgery to return thinned blood to its normal state.   view more (2005-08-01)

Drug could change the standard treatment during procedures to clear blocked arteries
A study led by a University of Kentucky researcher being published in the country's leading medical journal could one day change the standard treatment for preventing blood clots during procedures to open up blocked arteries feeding the heart.   view more (2006-09-11)

Study finds room for improvement in angioplasty, shows what can be done to cut risks
Each year, more than 600,000 Americans have angioplasty procedures to open clogged arteries near their hearts, and treat or prevent a heart attack.   view more (2006-02-13)

New guidelines issued for diagnosis and management of venous thromboembolism
The American Academy of Family Physicians (AAFP) and American College of Physicians (ACP) today released new clinical practice guidelines for the diagnosis and management of venous thromboembolism (VTE).   view more (2007-01-30)

Enoxaparin beats unfractionated heparin as adjunct therapy for heart attacks
A simple-to-use strategy that prevents blood clots in patients who have suffered a heart attack markedly reduces the risk of repeat heart attack or death when compared to an older, more widely used blood thinning strategy.   view more (2006-03-15)

Study helps explain how allergic reactions are triggered
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the... view more... (2008-01-15)

New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.   view more (2008-06-25)

Impact of fondaparinux tested on most serious heart attacks
The results of a large international cardiovascular trial will shed light on whether the addition of a new drug that prevents blood clotting, or thrombosis, can improve the treatment of the most serious form of heart attacks.   view more (2006-03-15)

Safety of antithrombotic treatment in acute coronary syndromes
The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion.   view more (2008-09-03)
Sort By: Relevance | Date
© 2009 BrightSurf.com